The Broad Implications of The SAUL Study
Dr. Cora Sternberg Of Weill Cornell Medicine and NewYork-Presbyterian discusses the broader implications of the SAUL study.<br /><br />Background: Atezo, a monoclonal antibody targeting PD-L1, is an approved ...
Author: Annual-Meeting
Added: 06/07/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Study